Evidence for HTR1A and LHPP as interacting genetic risk factors in major depression

Molecular Psychiatry

Volumn 14, Issue 6, 2009, Pages 621-630

  Neff, C D ^a   Abkevich, V ^b   Packer, J C L ^b   Chen, Y ^a   Potter, J ^a   Riley, R ^a   Davenport, C ^a   DeGrado Warren, J ^a   Jammulapati, S ^a   Bhathena, A ^b   Choi, W S ^b   Kroeger, P E ^b   Metzger, R E ^b   Gutin, A ^a   Skolnick, M H ^a   Shattuck, D ^a   Katz, D A ^b  

^a Myriad Genetic Laboratories   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

Epistasis; Genetic association; Genetic linkage; Major depression; Serotonin receptor

Indexed keywords

SEROTONIN 1A RECEPTOR;

ARTICLE; CHROMOSOME 10; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENE FREQUENCY; GENETIC LINKAGE; GENETIC RISK; GENOTYPE; HTR1A GENE; HUMAN; LHPP GENE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; NUCLEOTIDE SEQUENCE; POPULATION GENETICS; PRIORITY JOURNAL; RECEPTOR GENE; RISK ASSESSMENT; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED STATES;

CHROMOSOMES, HUMAN, PAIR 10; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; HUMANS; INORGANIC PYROPHOSPHATASE; JEWS; LINKAGE (GENETICS); MALE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, SEROTONIN, 5-HT1A; RISK FACTORS; UTAH;

EID: 66249095647     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2008.8     Document Type: Article

References (45)

1. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability From Disease, Injuries, and Risk Factors in 1990 and Projected to 2020. Harvard University Press: Cambridge MA, 1996.
2. Fava M, Davidson K. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Amer 1996; 19: 179-200.
3. Mann J, Emslie G, Baldessarini R, Beardsley W, Fawcett J, Goodwin F et al. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacol 2006; 31: 473-492.
4. Mueller T, Leon A, Keller M, Solomon D, Endicott J, Coryell W et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999; 156: 1000-1006.
5. Mann J. Drug therapy: the medical management of depression. New Engl J Med 2005; 353: 1819-1834.
6. Abkevich V, Camp N, Hensel C, Neff C, Russell D, Hughes D et al. Predisposition locus for major depression at chromosome 12q22- 12q23.2. Am J Hum Genet 2003; 73: 1271-1281.
7. Thomas A, Gutin A, Abkevich V, Bansal A. Multilocus linkage analysis by blocked Gibbs sampling. Stat Comp 2000; 10: 259-269.
8. Lemonde S, Turecki G, Bakish D, Du L, Hrdina P, Bown C et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003; 23: 8788-8799.
9. Arias B, Arranz M, Gasto C, Catalan R, Pintor L, Gutierrez B et al. Analysis of structural polymorphisms and C-1018G promoter variant of the 5-HT1A receptor gene as putative risk factors in major depression. Mol Psychiatry 2002; 7: 930-932.
10. Arias B, Catalán R, Gastó C, Gutiérrez B, Fañanás L. Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram. J Psychopharmacol 2005; 19: 166-172.
11. Huang Y-Y, Battistuzzi C, Oquendo M, Harkavy-Friedman J, Greenhill L, Zalsman G et al. Human 5-HT1A receptor C( - 1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 2004; 7: 441-451.
12. Lemonde S, Du L, Bakish D, Hrdina P, Albert P. Association of the C( - 1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 2004; 7: 501-506.
13. Rothe C, Gutknecht L, Freitag C, Tauber R, Mössner R, Franke P et al. Association of a functional - 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int J Neuropsychopharmacol 2004; 7: 189-192.
14. Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R. The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol 2004; 7: 453-460.
15. Strobel A, Gutknecht L, Rothe C, Reif A, Mössner R, Zeng Y et al. Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J Neural Trans 2003; 110: 1445-1453.
16. Pruitt K, Tatusova T, Maglott D. NCBI reference sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucl Acids Res 2005; 33: D501-D504.
17. Finn R, Mistry J, Schuster-Böckler B, Griffiths-Jones S, Hollich V, Lassmann T et al. Pfam: clans, web tools and services. Nucl Acids Res 2006; 34: D247-D251.
18. Felsenstein J. PHYLIP - phylogeny inference package (Version 3.2). Cladistics 1989; 5: 164-166.
19. Page R. TreeView: an application to display phylogenetic trees on personal computers. Comp Appl Biosci 1996; 12: 357-358.
20. Barrett J, Fry B, Maller J, Daly M. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
21. Barnes N, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacol 1999; 38: 1083-1152.
22. Wu S, Comings D. A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 1999; 9: 105-106.
23. Harlan J, Chen Y, Gubbins E, Mueller R, Roch J-M, Walter K et al. Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol Psychiatry 2006; 11: 76-85.
24. Seal U, Binkley F. An inorganic pyrophosphatase of swine brain. J Biol Chem 1957; 228: 193-199.
25. Felix R, Fleisch H. Properties of inorganic pyrophosphatase of pig scapula cartilage. Biochem J 1975; 147: 111-118.
26. Hachimori A, Fujii T, Ohki K, Iizuka E. Purification and properties of inorganic pyrophosphatase from porcine brain. J Biochem 1983; 93: 257-264.
27. Smirnova I, Baykov A. Reversible inactivation of rat liver inorganic pyrophosphatase by substrate and its analogs. Arch Biochem Biophys 1991; 287: 135-140.
28. Yoshida C, Shah H, Weinhouse S. Purification and properties of inorganic pyrophosphatase of rat liver and hepatoma 3924A. Cancer Res 1982; 42: 3526-3531.
29. Yokoi F, Hiraishi H, Izuhara K. Molecular cloning of a cDNA for the human phospholysine phosphohistidine inorganic pyrophosphate phosphatase. J Biochem 2003; 133: 607-614.
30. Hiraishi H, Yokoi F, Kumon A. 3-phosphohistidine and 6-phospholysine are substrates of a 56-kDa inorganic pyrophosphatase from bovine liver. Arch Biochem Biophys 1998; 349: 381-387.
31. Harrison P, Weinberger D. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68.
32. Hashimoto L, Habita C, Beressi J, Delepine M, Basse C, Cambon-Thomsen A et al. Genetic mapping of a susceptibility locus for insulin dependent diabetes mellitus on chromosome 11q. Nature 1994; 371: 161-164.
33. Zubenko GS, Maher B, Hughes 3rd HB, Zubenko WN, Stiffler JS, Kaplan BB et al. Genome-wide linkage survey for genetic loci that influence the development of depressive disorders in families with recurrent, early-onset, major depression. Am J Med Genet 2003; 123B: 1-18.
34. Saviouk V, Chow E, Bassett A, Brzustowicz L. Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44. Mol Psychiatry 2005; 10: 375-383.
35. Stone S, Abkevich V, Russell D, Riley R, Timms K, Tran T et al. TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet 2006; 15: 2709-2720.
36. Stock J, Stock A, Mottonen J. Signal transduction in bacteria. Nature 1990; 344: 395-400.
37. Klumpp S, Krieglstein J. Phosphorylation and dephosphorylation of histidine residues in proteins. Eur J Biochem 2002; 269: 1067-1071.
38. Matthews H. Protein kinases and phosphatases that act on histidine, lysine, or arginine residues in eukaryotic proteins: a possible regulator of the mitogen-activated protein kinase cascade. Pharmacol Ther 1995; 67: 323-350.
39. Cuello F, Schulze R, Heemeyer F, Meyer H, Lutz S, Jakobs K et al. Activation of heterotrimeric G proteins by a high energy phosphate transfer via nucleoside diphosphate kinase (NDPK) B and Gβ subunits: complex formation of NDPK B with Gβγ dimers and phosphorylation of His-266 in Gβ. J Biol Chem 2003; 278: 7220-7226.
40. Hohenegger M, Mitterauer T, Voss T, Nanoff C, Freissmuth M. Thiophosphorylation of the G protein β subunit in human platelet membranes: evidence against a direct phosphate transfer reaction to Gα subunits. Mol Pharmacol 1996; 49: 73-80.
41. Kowluru A. Regulatory roles for small G proteins in the pancreatic β-cell: lessons from models of impaired insulin secretion. Am J Physiol Endocrinol Metab 2003; 285: E669-E684.
42. Randazzo P, Northrup J, Kahn R. Activation of a small GTP-binding protein by nucleoside diphosphate kinase. Science 1991; 254: 850-853.
43. Wieland T, Nürnberg B, Ulibarri I, Kaldenberg-Stasch S, Schultz G, Jakobs K. Guanine nucleotide-specific phosphate transfer by guanine nucleotide-binding regulatory protein β-subunits: characterization of the phosphorylated amino acid. J Biol Chem 1993; 268: 18111-18118.
44. Chi H, Tiller G, Dasouki M, Romano P, Wang J, O'Keefe R et al. Multiple inositol polyphosphate phosphatase: evolution as a distinct group within the histidine phosphatase family and chromosomal localization of the human and mouse genes to chromosomes 10q23 and 19. Genomics 1999; 56: 324-336.
45. Ek P, Pettersson G, Ek B, Gong F, Li J-P, Zetterqvist Ö . Identification and characterization of a mammalian 14-kDa phosphohistidine phosphatase. Eur J Biochem 2002; 269: 5016-5023.